
Overview
Background
I lead the extracellular vesicle (EV) diagnostic and therapeutic research theme within the Centre for Personalised Nanomedicine at the Australian Institute for Bioengineering and Nanotechnology (AIBN). My expertise spans EV biology, hypoxia research, cancer metastasis, and cancer immunology. At the AIBN, my research program focuses on developing innovative approaches to engineer therapeutic EVs and develop cutting-edge technologies to profile circulating EVs in the bloodstream. I have made significant conceptual contributions in the field through new analytical techniques and optimal isolation methodologies for EVs. This has been fundamental to the field and has contributed to overcoming the limitations of existing purification protocols that have hindered the potential translational applications of EVs in cancer.
Availability
- Dr Richard Lobb is:
- Available for supervision
Qualifications
- Doctor of Philosophy, The University of Queensland
Research interests
-
Extracellular Vesicles
Clinical interest in extracellular vesicles (EVs) has heightened as accumulating evidence underscores their significance in intercellular communication. Small EVs, or exosomes, are constitutively secreted lipid bilayer vesicles across cell lineages, ranging from 30 to 150 nm in size. These vesicles contain a diverse molecular cargo comprising proteins, lipids, various RNA species (mRNA, miRNA, lncRNA), and DNA molecules (dsDNA, ssDNA, mtDNA). Consequently, EVs have emerged as potential biomarkers, offering prospects for monitoring cancer progression and serving as targets for therapeutic interventions. Notably, cancer-derived small EVs (sEVs) are detectable in a range of bodily fluids, including blood, urine, mucus, and bronchial fluids, thereby rendering them exploitable in liquid biopsy approaches.
-
Therapeutics
The ability of small EVs to transfer biomolecules between cells highlights their potential in modulating intercellular communication for therapeutic purposes. Small EVs possess natural traits that facilitate effective drug delivery, including their ability to traverse biological barriers and be administered via various routes, offering flexibility in treatment strategies. These inherent advantages can be exploited with precise bioengineering of EV membrane proteins for targeted distribution to specific organs and cell types, improving therapeutic outcomes while minimizing unintended effects. As a result, EVs as an advanced bionanoparticle therapeutic may represent next-generation drug delivery resulting in safer and more effective therapies
Works
Search Professor Richard Lobb’s works on UQ eSpace
2018
Other Outputs
Exosomes in the disease progression of non-small cell lung cancer (NSCLC) patients. Exosomes as biomarkers in NSCLC
Lobb, Richard John (2018). Exosomes in the disease progression of non-small cell lung cancer (NSCLC) patients. Exosomes as biomarkers in NSCLC. PhD Thesis, School of Medicine, The University of Queensland. doi: 10.14264/uql.2018.236
2017
Journal Article
Oncogenic transformation of lung cells results in distinct exosome protein profile similar to the cell of origin
Lobb, Richard J., Hastie, Marcus L., Norris, Emma L., van Amerongen, Rosa, Gorman, Jeffrey J. and Möller, Andreas (2017). Oncogenic transformation of lung cells results in distinct exosome protein profile similar to the cell of origin. Proteomics, 17 (23-24) 1600432, 1-10. doi: 10.1002/pmic.201600432
2017
Journal Article
Exosomes derived from mesenchymal non-small cell lung cancer cells promote chemoresistance
Lobb, Richard J., van Amerongen, Rosa, Wiegmans, Adrian, Ham, Sunyoung, Larsen, Jill E. and Moller, Andreas (2017). Exosomes derived from mesenchymal non-small cell lung cancer cells promote chemoresistance. International Journal of Cancer, 141 (3), 614-620. doi: 10.1002/ijc.30752
2017
Journal Article
An electrochemical method for the detection of disease-apecific exosomes
Yadav, Sharda, Boriachek, Kseniia, Islam, Md Nazmul, Lobb, Richard, Moller, Andreas, Hill, Michelle M., Hossain, Md Shahriar Al, Nguyen, Nam-Trung and Shiddiky, Muhammad J. A. (2017). An electrochemical method for the detection of disease-apecific exosomes. ChemElectroChem, 4 (4), 967-971. doi: 10.1002/celc.201600391
2017
Journal Article
Unique molecular profile of exosomes derived from primary human proximal tubular epithelial cells under diseased conditions
Wang, Xiangju, Wilkinson, Ray, Kildey, Katrina, Potriquet, Jeremy, Mulvenna, Jason, Lobb, Richard J., Moller, Andreas, Cloonan, Nicole, Mukhopadhyay, Pamela, Kassianos, Andrew J. and Healy, Helen (2017). Unique molecular profile of exosomes derived from primary human proximal tubular epithelial cells under diseased conditions. Journal of Extracellular Vesicles, 6 (1) 1314073, 1314073-1314073. doi: 10.1080/20013078.2017.1314073
2017
Journal Article
Exosomes: key mediators of metastasis and pre-metastatic niche formation
Lobb, Richard J., Lima, Luize G. and Moller, Andreas (2017). Exosomes: key mediators of metastasis and pre-metastatic niche formation. Seminars in Cell and Developmental Biology, 67, 3-10. doi: 10.1016/j.semcdb.2017.01.004
2017
Book Chapter
Size exclusion chromatography: a simple and reliable method for exosome purification
Lobb, Richard and Moller, Andreas (2017). Size exclusion chromatography: a simple and reliable method for exosome purification. In Winston Patrick Kuo and Shidong Jia (Ed.), Extracellular vesicles: methods and protocols (pp. 105-110) New York, NY, United States: Humana Press. doi:10.1007/978-1-4939-7253-1_9
2016
Journal Article
The biodistribution and immune suppressive effects of breast cancer-derived exosomes
Wen, Shu Wen, Sceneay, Jaclyn, Lima, Luize Goncalves, Wong, Christina S. F., Becker, Melanie, Krumeich, Sophie, Lobb, Richard J., Castillo, Vanessa, Wong, Ke Ni, Ellis, Sarah, Parker, Belinda S. and Moller, Andreas (2016). The biodistribution and immune suppressive effects of breast cancer-derived exosomes. Cancer Research, 76 (23), 6816-6827. doi: 10.1158/0008-5472.CAN-16-0868
2016
Journal Article
Radiotherapy for non-small cell lung cancer induces DNA damage response in both irradiated and out-of-field normal tissues
Siva, Shankar, Lobachevsky, Pavel, MacManus, Michael P., Kron, Tomas, Möller, Andreas, Lobb, Richard J., Ventura, Jessica, Best, Nickala, Smith, Jai, Ball, David and Martin, Olga A. (2016). Radiotherapy for non-small cell lung cancer induces DNA damage response in both irradiated and out-of-field normal tissues. Clinical Cancer Research, 22 (19), 4817-4826. doi: 10.1158/1078-0432.CCR-16-0138
2015
Conference Publication
Purification and Analysis of Exosomes Derived From Primary Human Proximal Epithelial Cells (Ptec)
Wang, X., Kassianos, A. J., Potriquet, J., Lobb, R., Wilkinson, R. and Healy, H. (2015). Purification and Analysis of Exosomes Derived From Primary Human Proximal Epithelial Cells (Ptec). 51st Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Canberra, Australia, 7-9 September 2015. HOBOKEN: WILEY-BLACKWELL.
2015
Journal Article
Optimized exosome isolation protocol for cell culture supernatant and human plasma
Lobb, Richard J., Becker, Melanie, Wen, Shu Wen, Wong, Christina S. F., Wiegmans, Adrian P., Leimgruber, Antione and Moller, Andreas (2015). Optimized exosome isolation protocol for cell culture supernatant and human plasma. Journal of Extracellular Vesicles, 4 (1) 27031, 27031. doi: 10.3402/jev.v4.27031
2014
Journal Article
Exosomes in cancer metastasis: Novel targets for diagnosis and therapy?
Wen, Shu Wen, Lobb, Richard and Moller, Andreas (2014). Exosomes in cancer metastasis: Novel targets for diagnosis and therapy?. Cancer Forum, 38 (2), 116-120.
Supervision
Availability
- Dr Richard Lobb is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Available projects
-
Projects in therapeutic approaches and monitoring of patients with brain cancer
- Developing novel translational nanotechnology for monitring extracellular vesicles realsed from the brain
- Deveoping extracellular vesicle therapeutics for brain cancer
-
Multiplexed nanotechnology platform to monitor glioblastoma and metastatic brain lesion risk
Develop a diagnostic and prognostic liquid biopsy nanotechnology platform for monitoring brain cancer progression and risk of brain metastases by mapping the phenotype of extracellular vesicles in the blood.
-
Projects in therapeutic approaches and monitoring of patients with brain cancer
- Developing novel translational nanotechnology for monitring extracellular vesicles realsed from the brain
- Deveoping extracellular vesicle therapeutics for brain cancer
-
Multiplexed nanotechnology platform to monitor glioblastoma and metastatic brain lesion risk
Develop a diagnostic and prognostic liquid biopsy nanotechnology platform for monitoring brain cancer progression and risk of brain metastases by mapping the phenotype of extracellular vesicles in the blood.
-
Multiplexed nanotechnology platform to monitor glioblastoma and metastatic brain lesion risk
Develop a diagnostic and prognostic liquid biopsy nanotechnology platform for monitoring brain cancer progression and risk of brain metastases by mapping the phenotype of extracellular vesicles in the blood.
-
Multiplexed nanotechnology platform to monitor glioblastoma and metastatic brain lesion risk
Develop a diagnostic and prognostic liquid biopsy nanotechnology platform for monitoring brain cancer progression and risk of brain metastases by mapping the phenotype of extracellular vesicles in the blood.
-
Multiplexed nanotechnology platform to monitor glioblastoma and metastatic brain lesion risk
Develop a diagnostic and prognostic liquid biopsy nanotechnology platform for monitoring brain cancer progression and risk of brain metastases by mapping the phenotype of extracellular vesicles in the blood.
Supervision history
Current supervision
-
Doctor Philosophy
Investigating therapeutic potentials of brain-derived exosomes
Principal Advisor
Other advisors: Professor Matt Trau, Dr Christopher Howard
-
Doctor Philosophy
The investigation of microglial activation in brain cancer and brain metastasis by an integrated nano-sensor
Principal Advisor
Other advisors: Professor Matt Trau, Dr Alain Wuethrich
-
Doctor Philosophy
Single Molecule Readout of Immune Disfunction
Associate Advisor
Other advisors: Dr Alain Wuethrich, Professor Matt Trau
-
Doctor Philosophy
Multi-Factor Authentication of Extracellular Vesicles in Clinical Settings
Associate Advisor
Other advisors: Dr Alain Wuethrich, Professor Matt Trau
-
Doctor Philosophy
Utilising extracellular vesicles for the diagnosis of lung cancer.
Associate Advisor
Other advisors: Dr Alain Wuethrich, Professor Matt Trau
-
Doctor Philosophy
Utilising extracellular vesicles for the diagnosis of lung cancer.
Associate Advisor
Other advisors: Dr Alain Wuethrich, Professor Matt Trau
-
Doctor Philosophy
Digital Nanotechnologies to track molecular aberrations in cancer
Associate Advisor
Other advisors: Dr Alain Wuethrich, Professor Matt Trau
Media
Enquiries
For media enquiries about Dr Richard Lobb's areas of expertise, story ideas and help finding experts, contact our Media team: